CANCELED: SPARK-BIH Educational Forum - May
Essential Regulatory Practice in the Development of Novel Therapies Dr. Gabriele Dallmann (Biopharma Excellence Munich)
+++ We are sorry to inform that due to the current situation regarding the Coronavirus (SARS-Cov-2), we are forced to cancel the SPARK-BIH Forum on 19 May 2020 +++
Everyone is invited to join our SPARK-BIH Lecture Series taught by SPARK advisors and experts. The lectures take place ~once a month on Tuesdays from 5 to 7 pm.
For our May-Forum we are very excited to welcome Dr. Gabriele Dallmann as speaker.
Agenda
5 pm: Essential Regulatory Practice in the Development of Novel Therapies
Dr. Gabriele Dallmann (Biopharma Excellence Munich)
Networking Event with Wine & Cheese!
After the presentations, you will have time to meet the speaker and pose questions.
Registration
We look very much forward to welcoming you at our Forum - a registration is not required!
Lecture Series
We currently offer two public Lecture Series, which alternate each month:
The SPARK-BIH Educational Forum is designed to teach academic scholars the principles of Drug, Device & Diagnostic Development with focus on topics which are relevant for translational medicine.
In our SPARK-BIH Entrepreneurial Forum we recruit key opinion leaders in the fields of Business Planning & Development, Financing and Commercialization to teach entrepreneurial scientists.
SPARK-BIH is an initiative created at Stanford University, to overcome challenges associated with translation of academic discoveries.
When
May 19, 2020
5 - 7 pm
Where
Kaiserin Friedrich-Haus
Robert-Koch-Platz 7
Galerieraum EG
10115 Berlin
Unfortunately the venue can only partially be accessed barrier-free. If you need help regarding barrier-free access or have any questions regarding the accessibility of the venue, please contact us in advance: [email protected] (030-450 543 057)
Childcare Service
We offer childccare during the event. Should this be of interest to you please let us know at least 14 days in advance of the event by sending an email to: [email protected]